ACTIVE

INTERNATIONAL MEDICAL PRODUCTS

Financial year 2025 · Closed on 31/12/2025

Net result984,3 k €-2,2 %over 1 year
Revenue23,8 M €-11,9 %over 1 year
Equity4,2 M €+30,4 %over 1 year
Workforce16,3 ETP+1,9 %over 1 year

Identity

Source · BCE/KBO

INTERNATIONAL MEDICAL PRODUCTS is a Public limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Saint-Gilles. It employs on average 16,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0426.041.123
Incorporation
03/08/1984
Legal form
Public limited company
Registered office
Place Marcel Broodthaers 8 box 5
1060 Saint-Gilles · BruxellesSee on map
Contributed capital
1 139 166,54 €
Latest accounts
31/12/2025
Average workforce
16,3 ETP
Joint committees (3)
  • 116
  • 200
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Revenue23,8 M €27 M €25,7 M €24,5 M €22,9 M €
EBITDA978,7 k €1,3 M €1,3 M €-866,2 k €261,9 k €
Operating result880 k €1,2 M €839,6 k €-1,1 M €44 k €
Net result984,3 k €1 M €1,1 M €-357,2 k €-68,7 k €
Balance sheet
Equity4,2 M €3,2 M €2,2 M €1,1 M €1,5 M €
Total assets10,2 M €10,9 M €10,5 M €10,7 M €12,1 M €
Cash327,6 k €65,7 k €215,7 k €400,2 k €1,6 M €
Debts5,9 M €7,7 M €7,6 M €9,6 M €10,4 M €
Other
Workforce16,3 ETP16,0 ETP16,3 ETP17,4 ETP21,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 45 ended

Active mandates

NATALIS DEVELOPPEMENT SAS

Managing director · since 31 mars 2026 · until 07 mai 2031

Represented by Vincent Camus

Active
JESSICA WEVE

Director · since 06 mai 2025 · until 07 mai 2031

Active
MB SOLUTIONS

Director · since 06 mai 2025 · until 07 mai 2031 · 0795.803.935

Represented by MARC BEMELMANS

Active

Ended mandates

MB SOLUTIONS

Director · since 01 février 2023 · until 07 mai 2025 · 0795.803.935

Represented by MARC BEMELMANS

Ended
JESSICA WEVE

Director · since 11 novembre 2022 · until 07 mai 2025

Ended
MARC BEMELMANS

Director · since 26 mars 2021 · until 01 février 2023

Ended
MARC BEMELMANS

Director · since 26 mars 2021 · until 31 décembre 2024

Ended

Other companies at this address

Place Marcel Broodthaers 8 1060 Saint-Gilles
CompanyCBE no.
ABBA● Active
0726.455.170
0818.427.701
ADISTA BELGIQUE● Active
1009.851.459
0802.313.229
AMEDTRANS● Active
0733.661.577
1036.953.061
Androlabs● Active
1036.584.065
0734.933.366
ASBRI● Active
1025.981.272
ASK LOCALA● Active
0718.919.359
0629.752.902
1011.289.534
0693.764.388
BELLFORT● Active
0695.557.997
BELSORG● Active
0891.985.274
BILIUS● Active
0775.483.821
BONNE ROUTE● Active
0746.473.396
Bouw Team● Active
0689.613.184
Bowe Systec● Active
0458.430.908
BREMSTEIN● Active
0452.965.056

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date05/06/202609/05/202513/06/202404/07/202307/07/202218/06/2021
General meeting13/05/202606/05/202507/06/202428/06/202324/06/202216/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202513/05/202605/06/2026FrenchPDF
Full model31/12/202406/05/202509/05/2025FrenchPDF
Full model31/12/202307/06/202413/06/2024FrenchPDF
Full model31/12/202228/06/202304/07/2023FrenchPDF
Full model31/12/202124/06/202207/07/2022FrenchPDF
Full model31/12/202016/06/202118/06/2021FrenchPDF
Full model31/12/201917/06/202021/09/2020FrenchPDF
Full model31/12/201817/06/202007/07/2020FrenchPDF
Full model31/12/201715/05/201815/06/2018FrenchPDF
Full model31/12/201602/05/201718/05/2017FrenchPDF
Full model31/12/201503/06/201613/06/2016FrenchPDF
Full model31/12/201405/05/201519/06/2015FrenchPDF
Full model31/12/201306/05/201411/06/2014FrenchPDF
Full model31/12/201207/05/201312/06/2013FrenchPDF
Full model31/12/201102/05/201208/06/2012FrenchPDF
Full model31/12/201030/05/201107/06/2011FrenchPDF
Full model31/12/200904/05/201001/06/2010FrenchPDF
Full model31/12/200805/05/200918/05/2009FrenchPDF
Full model31/12/200706/05/200829/05/2008FrenchPDF
Full model31/12/200601/05/200724/05/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 45 ended

Active mandates

NATALIS DEVELOPPEMENT SAS

Managing director · since 31 mars 2026 · until 07 mai 2031

Represented by Vincent Camus

Active
JESSICA WEVE

Director · since 06 mai 2025 · until 07 mai 2031

Active
MB SOLUTIONS

Director · since 06 mai 2025 · until 07 mai 2031 · 0795.803.935

Represented by MARC BEMELMANS

Active

Ended mandates

MB SOLUTIONS

Director · since 01 février 2023 · until 07 mai 2025 · 0795.803.935

Represented by MARC BEMELMANS

Ended
JESSICA WEVE

Director · since 11 novembre 2022 · until 07 mai 2025

Ended
MARC BEMELMANS

Director · since 26 mars 2021 · until 01 février 2023

Ended
MARC BEMELMANS

Director · since 26 mars 2021 · until 31 décembre 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/08/2026
    Renomination de KPMG en tant que commissaire pour le mandait 2026-
    PDF
  • Mandates14/07/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/10/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/03/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates15/03/2023
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares08/03/2022
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates23/04/2021
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025984,3 k €↓
  2. 2024
    Annual accounts 20241 M €↓
  3. 2023
    Annual accounts 20231,1 M €↑
  4. 2023
    Name changeIMP
  5. 2022
    Annual accounts 2022-357,2 k €↓
  6. 2021
    Annual accounts 2021-68,7 k €↑
  7. 2021
    Name changeINTERNATIONAL MEDICAL PRODUCTS
  8. 2020
    Annual accounts 2020-527 k €↓
  9. 2019
    Annual accounts 2019-81,5 k €↑
  10. 2018
    Annual accounts 2018-627,8 k €↓
  11. 2017
    Annual accounts 2017-269 k €↑
  12. 2016
    Annual accounts 2016-398,3 k €↑
  13. 2015
    Annual accounts 2015-3 M €↓
  14. 2014
    Annual accounts 2014198,9 k €↓
  15. 2013
    Annual accounts 2013540,7 k €↑
  16. 2012
    Annual accounts 2012165,1 k €↓
  17. 2011
    Annual accounts 2011365 k €↓
  18. 2010
    Annual accounts 2010445,5 k €↓
  19. 2009
    Annual accounts 2009455,1 k €↓
  20. 2008
    Annual accounts 2008566,1 k €↑
  21. 2007
    Annual accounts 2007555,3 k €↑
  22. 2006
    Annual accounts 2006428,8 k €
  23. 03/08/1984
    IncorporationPublic limited company